Literature DB >> 32502134

Justification of the Safety and Efficacy of Angiotensin II for the Treatment of SARS-CoV-Induced Shock.

Jonathan H Chow1, Michael A Mazzeffi, Michael T McCurdy.   

Abstract

Year:  2020        PMID: 32502134      PMCID: PMC7288781          DOI: 10.1213/ANE.0000000000005047

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


× No keyword cloud information.
  7 in total

1.  Outcomes in Patients with Vasodilatory Shock and Renal Replacement Therapy Treated with Intravenous Angiotensin II.

Authors:  James A Tumlin; Raghavan Murugan; Adam M Deane; Marlies Ostermann; Laurence W Busse; Kealy R Ham; Kianoush Kashani; Harold M Szerlip; John R Prowle; Azra Bihorac; Kevin W Finkel; Alexander Zarbock; Lui G Forni; Shannan J Lynch; Jeff Jensen; Stew Kroll; Lakhmir S Chawla; George F Tidmarsh; Rinaldo Bellomo
Journal:  Crit Care Med       Date:  2018-06       Impact factor: 7.598

2.  Sensitivity to angiotensin II dose in patients with vasodilatory shock: a prespecified analysis of the ATHOS-3 trial.

Authors:  Kealy R Ham; David W Boldt; Michael T McCurdy; Laurence W Busse; Raphael Favory; Michelle N Gong; Ashish K Khanna; Stefan N Chock; Feng Zeng; Lakhmir S Chawla; George F Tidmarsh; Marlies Ostermann
Journal:  Ann Intensive Care       Date:  2019-06-03       Impact factor: 6.925

3.  Angiotensin I and angiotensin II concentrations and their ratio in catecholamine-resistant vasodilatory shock.

Authors:  Rinaldo Bellomo; Richard G Wunderink; Harold Szerlip; Shane W English; Laurence W Busse; Adam M Deane; Ashish K Khanna; Michael T McCurdy; Marlies Ostermann; Paul J Young; Damian R Handisides; Lakhmir S Chawla; George F Tidmarsh; Timothy E Albertson
Journal:  Crit Care       Date:  2020-02-06       Impact factor: 9.097

4.  Angiotensin II infusion in COVID-19-associated vasodilatory shock: a case series.

Authors:  Alberto Zangrillo; Giovanni Landoni; Luigi Beretta; Federica Morselli; Ary Serpa Neto; Rinaldo Bellomo
Journal:  Crit Care       Date:  2020-05-15       Impact factor: 9.097

5.  Angiotensin II for the Treatment of COVID-19-Related Vasodilatory Shock.

Authors:  Jonathan H Chow; Michael A Mazzeffi; Michael T McCurdy
Journal:  Anesth Analg       Date:  2020-07       Impact factor: 5.108

6.  Unexpected BP Sensitivity to Angiotensin II in a Patient With Coronavirus Disease 2019, ARDS, and Septic Shock.

Authors:  Hanyin Wang; Subhraleena Das; Patrick M Wieruszewski; Jamil Taji; Brian Bartlett; Nabila Azad; Arnab Chowdhury; Gururaj J Kolar; Nitesh Jain; Mir R Subla; Syed Anjum Khan
Journal:  Chest       Date:  2020-04-23       Impact factor: 9.410

7.  Is Angiotensin II Unopposed a Good Thing?

Authors:  Ricardo E Verdiner
Journal:  Anesth Analg       Date:  2020-09       Impact factor: 6.627

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.